ARV-771 reduces cell proliferation and induces apoptosis substantially more effectively than the BRD4 inhibitor JQ1 and OTX015 in castration-resistant prostate cancer and diffuse large B cell lymphoma cells [59, 60]. The gene discussed is BRD4; the disease is prostate carcinoma.